Literature DB >> 12643206

Risk predictors in patients with diabetic nephropathy.

P Fioretto1, M L Caramori, M Dalla Vestra, M Mauer.   

Abstract

Diabetic nephropathy is currently the most common cause of end-stage renal disease in the Western countries. Only approximately one third of patients with type 1 diabetes develop nephropathy; thus, because it is not feasible to aggressively treat all patients, it becomes very important to find early markers in order to identify patients at high nephropathy risk. To date the best available predictor of overt nephropathy is microalbuminuria. In this article we review the validity of microalbuminuria as a predictor of overt nephropathy and consider other markers of nephropathy risk.

Entities:  

Mesh:

Year:  2001        PMID: 12643206     DOI: 10.1007/s11892-001-0042-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  46 in total

1.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; M Canessa; J H Warram; L M Laffel; A R Christlieb; W C Knowler; L I Rand
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

2.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Familial factors determine the development of diabetic nephropathy in patients with IDDM.

Authors:  M Quinn; M C Angelico; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

5.  Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria.

Authors:  H J Bangstad; R Osterby; K Dahl-Jørgensen; K J Berg; A Hartmann; G Nyberg; S Frahm Bjørn; K F Hanssen
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

6.  Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression.

Authors:  P Fioretto; M W Steffes; D E Sutherland; M Mauer
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

7.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

8.  Is diabetic nephropathy an inherited complication?

Authors:  K Borch-Johnsen; K Nørgaard; E Hommel; E R Mathiesen; J S Jensen; T Deckert; H H Parving
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria.

Authors:  J D Walker; C F Close; S L Jones; M Rafftery; H Keen; G Viberti; R Osterby
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  2 in total

1.  Meprin Metalloprotease Deficiency Associated with Higher Mortality Rates and More Severe Diabetic Kidney Injury in Mice with STZ-Induced Type 1 Diabetes.

Authors:  John E Bylander; Faihaa Ahmed; Sabena M Conley; Jean-Marie Mwiza; Elimelda Moige Ongeri
Journal:  J Diabetes Res       Date:  2017-07-19       Impact factor: 4.011

2.  Inflammation and Kidney Injury in Diabetic African American Men.

Authors:  Lei Cao; Ava Boston; Olugbemiga Jegede; Heather A Newman; Scott H Harrison; Robert H Newman; Elimelda Moige Ongeri
Journal:  J Diabetes Res       Date:  2019-02-05       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.